| 1 |
35589097 | Simultaneous Determination of Cortisol and 6β-Hydroxycortisol in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry. | 2022 May 20 |
2 |
| 2 |
33622083 | Using the CYP3A Activity Evaluation to Predict the Efficacy and Safety of Diazepam in Patients With Alcohol Withdrawal Syndrome. | 2021 Feb 24 |
1 |
| 3 |
33897064 | Impact of the Omics-Based Biomarkers on the Fluvoxamine's Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder. | 2021 Jan 12 |
2 |
| 4 |
34092821 | Impact of the Omics-Based Biomarkers on the Mirtazapine's Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder. | 2021 Mar 16 |
2 |
| 5 |
34390638 | MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring. | 2021 Aug 13 |
1 |
| 6 |
34633961 | [Adrenal crisis associated with modafinil use]. | 2021 |
2 |
| 7 |
34664787 | Studies on CYP3A activity during the menstrual cycle as measured by urinary 6β-hydroxycortisol/cortisol. | 2021 Dec |
3 |
| 8 |
34880651 | MicroRNAs as Novel Biomarkers for P2Y12 - Inhibitors Resistance Prediction. | 2021 |
1 |
| 9 |
34881490 | Dried blood spots analysis of 6β-hydroxycortisol and cortisol using liquid chromatography/tandem mass spectrometry for calculating 6β-hydroxycortisol to cortisol ratio. | 2021 Dec |
1 |
| 10 |
31608377 | Heritability of Cortisol Production and Metabolism Throughout Adolescence. | 2020 Feb 1 |
1 |
| 11 |
31721244 | A novel random forest integrative approach based on endogenous CYP3A4 phenotype for predicting tacrolimus concentrations and dosages in Chinese renal transplant patients. | 2020 Apr |
1 |
| 12 |
32001245 | Comparison of steroid hormone hydroxylation mediated by cytochrome P450 3A subfamilies. | 2020 Mar 30 |
2 |
| 13 |
32112986 | Effects of plasma concentration of micro-RNA Mir-27b and CYP3A4*22 on equilibrium concentration of alprazolam in patients with anxiety disorders comorbid with alcohol use disorder. | 2020 May 20 |
4 |
| 14 |
32656158 | Development and validation of a method for the simultaneous quantification of endogenous steroids metabolized by CYP3A. | 2020 Jun |
1 |
| 15 |
30683357 | Assessment of electrocatalytic hydroxylase activity of cytochrome P450 3A4 (CYP3A4) by means of derivatization of 6β-hydroxycortisol by sulfuric acid for fluorimetric assay. | 2019 May 1 |
1 |
| 16 |
30919109 | Mechanisms of CYP3A Induction During Pregnancy: Studies in HepaRG Cells. | 2019 Mar 27 |
6 |
| 17 |
31102151 | Genotyping and phenotyping CYP3A4\CYP3A5: no association with antiplatelet effect of clopidogrel. | 2019 Aug |
1 |
| 18 |
31339834 | Comparison of Steroid Hormone Hydroxylations by and Docking to Human Cytochromes P450 3A4 and 3A5. | 2019 |
3 |
| 19 |
31581123 | Adrenal insufficiency, be aware of drug interactions! | 2019 Oct 3 |
1 |
| 20 |
31603853 | The influence of taurine and L-carnitine on 6 β-hydroxycortisol/cortisol ratio in human urine of healthy volunteers. | 2019 Oct 11 |
6 |
| 21 |
29343979 | The influence of CYP3A5 polymorphisms on haloperidol treatment in patients with alcohol addiction. | 2018 |
1 |
| 22 |
29606886 | Influence of ABCB1 and CYP3A5 gene polymorphisms on pharmacokinetics of apixaban in patients with atrial fibrillation and acute stroke. | 2018 |
1 |
| 23 |
29780235 | The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo. | 2018 |
1 |
| 24 |
30607725 | A New Method for Quantitative Determination of Steroid Metabolites of Cytochrome P450-Dependent Reactions Using Fluorescent Spectroscopy. | 2018 Nov |
4 |
| 25 |
28157069 | Delayed de-induction of CYP2C9 compared to CYP3A after discontinuation of rifampicin: Report of two cases
. | 2017 May |
1 |
| 26 |
28787271 | Genotyping and phenotyping of CYP2D6 and CYP3A isoenzymes in patients with alcohol use disorder: correlation with haloperidol plasma concentration. | 2017 Sep 26 |
1 |
| 27 |
29075133 | Do CYP2C19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients? | 2017 |
2 |
| 28 |
26924289 | Prediction of tacrolimus metabolism and dosage requirements based on CYP3A4 phenotype and CYP3A5(*)3 genotype in Chinese renal transplant recipients. | 2016 Apr |
1 |
| 29 |
27317471 | Urinary 6β-Hydroxycortisol/Cortisol Ratio Most Highly Correlates With Midazolam Clearance Under Hepatic CYP3A Inhibition and Induction in Females: A Pharmacometabolomics Approach. | 2016 Sep |
4 |
| 30 |
27511886 | Associations of the CYP3A5*3 and CYP3A4*1G polymorphisms with the pharmacokinetics of oral midazolam and the urinary 6β-hydroxycortisol/cortisol ratio as markers of CYP3A activity in healthy male Chinese. | 2016 Oct |
1 |
| 31 |
25407158 | Alteration in cytochrome P450 3A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokinetics. | 2015 Mar |
1 |
| 32 |
25678418 | Regioselective hydroxylation of steroid hormones by human cytochromes P450. | 2015 May |
1 |
| 33 |
26639694 | CYP3A4 activity and haloperidol effects in alcohol addicts. | 2015 |
2 |
| 34 |
24468605 | Effect of ethosuximide on cortisol metabolism in the treatment of congenital adrenal hyperplasia. | 2014 May |
1 |
| 35 |
24611975 | The ratio of 6β-hydroxycortisol to cortisol in urine as a measure of cytochrome P450 3A activity in postmortem cases. | 2014 Jul |
1 |
| 36 |
23162091 | Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacement. | 2013 Jan |
3 |
| 37 |
23223499 | Induction of hepatic CYP3A enzymes by pregnancy-related hormones: studies in human hepatocytes and hepatic cell lines. | 2013 Feb |
4 |
| 38 |
23404385 | Association between urinary 6β-hydroxycortisol/cortisol ratio and CYP3A5 genotypes in a normotensive population. | 2013 Feb |
1 |
| 39 |
22120734 | Identification of pharmacogenetic predictors of lipid-lowering response to atorvastatin in Chilean subjects with hypercholesterolemia. | 2012 Feb 18 |
1 |
| 40 |
22253426 | Expression and regulation of human fetal-specific CYP3A7 in mice. | 2012 Mar |
1 |
| 41 |
22741198 | [Study on phenotypical activity of isoenzyme CYP3A4 in children]. | 2012 |
1 |
| 42 |
21114969 | Genotypes and phenotypes of CYP3A in Bangladeshi population. | 2011 Mar 18 |
1 |
| 43 |
21490593 | Evaluation of 6β-hydroxycortisol, 6β-hydroxycortisone, and a combination of the two as endogenous probes for inhibition of CYP3A4 in vivo. | 2011 Jun |
1 |
| 44 |
19959402 | Quantification of cortisol and 6 beta-hydroxycortisol in human urine by LC-MS/MS, and gender-specific evaluation of the metabolic ratio as biomarker of CYP3A activity. | 2010 Jan 1 |
2 |
| 45 |
20515961 | Oxcarbazepine accelerates cortisol elimination via cytochrome P450 3A4 induction. | 2010 Dec |
2 |
| 46 |
19621007 | A Holy Grail of clinical pharmacology: prediction of drug pharmacokinetics and pharmacodynamics in the individual patient. | 2009 Aug |
1 |
| 47 |
19701237 | Evaluation of CYP3A activity in humans using three different parameters based on endogenous cortisol metabolism. | 2009 Sep |
1 |
| 48 |
19690646 | Study of the Urinary Ratio of 6 beta-Hydroxycortisol/Cortisol as a Biomarker of CYP3A4 Activity in Egyptian Patients with Chronic Liver Diseases. | 2007 Feb 7 |
1 |
| 49 |
16433874 | Pharmacokinetics of ruboxistaurin are significantly altered by rifampicin-mediated CYP3A4 induction. | 2006 Feb |
1 |
| 50 |
16454691 | Cytochrome P450 and anticancer drugs. | 2006 Jan |
1 |